x 

0 Activities
0 Activities

Animation

The Role of Behavioral Medicine in Reducing Opiod Use

The Role of Behavioral Medicine in Reducing Opioid Use

Array

Activity Info

This activity focuses on utilizing behavioral medicine to reduce opioid use and covers all aspects of the core content outlined in the revised FDA Blueprint, with an emphasis on behavioral health and how the application of behavioral methods can help control pain. The content is broken down into four modules: The Basics of Pain Management, Creating the Pain Treatment Plan, Managing Patients with Pain on Opioid Analgesics, and Addiction Medicine Primer. This is an FDA REMS-compliant accredited CE activity.

Webcast Name: The Role of Behavioral Medicine in Reducing Opioid Use

Expiration Date: October 31, 2024

Learning Objectives

  • Describing the fundamental concepts of pain management
  • Assessing patients with pain, including mental health ie, depression, anxiety, etc, and identifying potential risk factors for opioid use disorder and who could benefit from behavioral health services
  • Utilizing the range of therapeutic options for managing pain, including nonpharmacologic approaches and pharmacologic (nonopioid and opioid analgesics) therapies with a focus on the inclusion of behavioral therapy
  • Managing patients on opioid analgesics safely and effectively in acute and chronic pain settings, including initiating therapy, titrating, and discontinuing use of opioid analgesics, with a focus on discontinuation of opioids and the use of behavioral medicine
  • Counseling patients and caregivers on the safe use of opioid analgesics along with behavioral medicine approaches
  • Counseling patients and caregivers about the use of naloxone for opioid overdose
  • Referring patients to a pain specialist, as appropriate
  • Utilizing the fundamental elements of addiction medicine (ie, diagnosis, prevention, evaluation, treatment, and recovery of patients with opioid use disorder)
  • Identifying and managing the care of patients with opioid use disorder including behavioral medicine approaches
  • Identifying current information about safe opioid practices and current federal and state regulations, national guidelines, and professional organization and medical specialty guidelines on treating pain and prescribing opioids
  • Detailing the use of naloxone and the importance of its availability for use by patients and caregivers in the community and home

Target Audience
The educational activity is directed to family medicine physicians, physician assistants and nurse practitioners who are registered with the DEA and who are eligible to prescribe all opioid analgesics, as well as non-prescribers who manage patients receiving opioid analgesic therapy, non-pharmacologic therapies, and nonopioid medication therapies for pain.

Accreditation


In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)
The Cleveland Clinic Center for Continuing Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


American Nurses Credentializing Center

American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 2.0 ANCC contact hours.


AAPA Physician Assistant

American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until 10/31/2024. PAs should only claim credit commensurate with the extent of their participation.

Activity Director

Amy Zack, MD
Department of Family Medicine
Vice Chair of Education
Primary Care Institute
Cleveland Clinic
Cleveland, OH

Faculty

Robert Bales, MD
Department of Family Medicine
Primary Care Institute
Center for Behavioral Health
Neurological Institute
Cleveland Clinic
Cleveland, OH

Richard W. Rosenquist, MD
Chairman, Pain Management Department
Cleveland Clinic
Cleveland, OH

Pavan Tankha, DO
Medical Director, Center for Comprehensive Pain Recovery
Neurological Institute
Cleveland Clinic
Cleveland, OH

Reviewers

Deb Kangisser, PA-C
Director of Education of PA Services
OPSA and Clinical Affairs
Cleveland Clinic
Cleveland, OH

David Streem, MD
Department of Psychiatry and Psychology
Chief of Psychiatry
Medical Director, Alcohol and Drug Recovery Center
Cleveland Clinic Lutheran Hospital
Cleveland, OH

Cindy Willis, DNP
Senior Director Nursing Education
Nursing Institute
Cleveland Clinic
Cleveland, OH

Disclosure

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty members have indicated that they may have a relationship which, in the context of their contribution, could be perceived as a potential conflict of interest.

To ensure mitigation of conflicts of interest, content was reviewed by a non-conflicted reviewer to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning.

Robert Bales, MD

ROMTech—Private Ownership or Partnership
* This relationship was reviewed, and the company’s business lines are unrelated to the content of this activity. ACCME exception criteria applies.

Richard Rosenquist, MD

Mainstay Medical Limited—Advisor/Review Panel Participant

The following faculty and reviewers have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

Deb Kangisser, PA-C
David Streem, MD
Pavan Tankha, DO
Cindy Willis, DNP
Amy Zack, MD

Cleveland Clinic Center for Continuing Education and The France Foundation staff report no relevant financial relationships to disclose.

Acknowledgement

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).